Taken together, these results suggest that the downregulation of ANT2 efficiently inhibits cell growth and proliferation by reducing ATP levels as well as inducing G1 arrest, which ultimately leads to the apoptosis of human breast cancer cells in vitro. Here, SLC25A5 is linked to breast cancer.